Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-042483
Filing Date
2019-11-12
Accepted
2019-11-12 06:16:35
Documents
66
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q surf-10q_20190930.htm 10-Q 2101291
2 EX-31.1 surf-ex311_9.htm EX-31.1 17660
3 EX-31.2 surf-ex312_7.htm EX-31.2 17691
4 EX-32.1 surf-ex321_6.htm EX-32.1 7059
5 EX-32.2 surf-ex322_8.htm EX-32.2 7122
  Complete submission text file 0001564590-19-042483.txt   7003488

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT surf-20190930.xml EX-101.INS 1444975
7 XBRL TAXONOMY EXTENSION SCHEMA surf-20190930.xsd EX-101.SCH 43229
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE surf-20190930_cal.xml EX-101.CAL 44556
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE surf-20190930_def.xml EX-101.DEF 173243
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE surf-20190930_lab.xml EX-101.LAB 381301
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE surf-20190930_pre.xml EX-101.PRE 319741
Mailing Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139 617-714-4096
Surface Oncology, Inc. (Filer) CIK: 0001718108 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38459 | Film No.: 191205797
SIC: 2836 Biological Products, (No Diagnostic Substances)